{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:34:58Z","timestamp":1769744098881,"version":"3.49.0"},"reference-count":32,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2020,4,15]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant disorder caused by germline mutations in fumarate hydratase (FH). Affected families have an increased risk of renal cell carcinoma (RCC). HLRCC-associated RCC (HLRCC-RCC) is highly aggressive. Clinicopathological information of genetically diagnosed patients with HLRCC-RCC contributes to the establishment of effective therapies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Ten Japanese patients with HLRCC-RCC were enrolled in the study. Genetic testing for <jats:italic>FH<\/jats:italic> was carried out. Somatic mutations in <jats:italic>FH<\/jats:italic> and immunohistochemical analyses of FH and B7 family ligands (PD-L1 and B7-H3) were investigated in 13 tumours. Copy number variations were evaluated in two tumours.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All patients had <jats:italic>FH<\/jats:italic> germline mutations. Regarding histology, most tumours had type 2 papillary architecture or tubulocystic pattern or both. All tumours were FH deficient by immunohistochemistry. Ten tumours were positive for PD-L1, and 12 tumours were positive for B7-H3. Somatic mutation analysis demonstrated loss of heterozygosity of <jats:italic>FH<\/jats:italic> in 10 tumours. Copy number variation analysis revealed uniparental disomy between 1q24.2 and 1q44 encompassing <jats:italic>FH<\/jats:italic>; gain of chromosome 2 p was also common. All patients had either metastases or residual tumours. Three patients died of HLRCC-RCC and one of colon cancer, whereas the other six are currently alive, including two without recurrence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HLRCC-RCCs appear to have unique molecular profiles, including PD-L1 expression. One patient had complete response to immunotherapy, which may be an option for HLRCC-RCC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2020-206548","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:27:39Z","timestamp":1588786059000},"page":"819-825","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas"],"prefix":"10.1136","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-8179","authenticated-orcid":false,"given":"Mitsuko","family":"Furuya","sequence":"first","affiliation":[{"name":"Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Iribe","sequence":"additional","affiliation":[{"name":"Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Surgical Pathology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotomo","family":"Kambe","sequence":"additional","affiliation":[{"name":"Dermatology, Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Ohe","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Urology, Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Sato","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kishida","sequence":"additional","affiliation":[{"name":"Urology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Okubo","sequence":"additional","affiliation":[{"name":"Pathology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Numakura","sequence":"additional","affiliation":[{"name":"Urology, Akita University Graduate School of Medicine School of Medicine, Akita, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nanjo","sequence":"additional","affiliation":[{"name":"Pathology, Akita University Graduate School of Medicine School of Medicine, Akita, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Nakaigawa","sequence":"additional","affiliation":[{"name":"Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Hasumi","sequence":"additional","affiliation":[{"name":"Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Iwashita","sequence":"additional","affiliation":[{"name":"Pathology, Yokohama Municipal Citizens Hospital, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ohta","sequence":"additional","affiliation":[{"name":"Urology, Yokohama Municipal Citizens Hospital, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Urology, University of Toyama Faculty of Medicine Graduate School of Medicine and Pharmaceutical Science for Education, Toyama, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, University of Toyama Faculty of Medicine Graduate School of Medicine and Pharmaceutical Science for Education, Toyama, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Urology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Urology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Chiba University Medical Mycology Research Center, Chiba, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yao","sequence":"additional","affiliation":[{"name":"Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"2025092503210991000_73.12.819.1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","article-title":"Cutaneous leiomyomata with uterine leiomyomata","volume":"53","author":"Reed","year":"1973","journal-title":"Acta Derm Venereol"},{"key":"2025092503210991000_73.12.819.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051633798"},{"key":"2025092503210991000_73.12.819.3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0304"},{"key":"2025092503210991000_73.12.819.4","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.033506"},{"key":"2025092503210991000_73.12.819.5","doi-asserted-by":"publisher","DOI":"10.1086\/376435"},{"key":"2025092503210991000_73.12.819.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-014-9735-2"},{"key":"2025092503210991000_73.12.819.7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2025092503210991000_73.12.819.8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cge.13014","article-title":"Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers","volume":"92","author":"Muller","year":"2017","journal-title":"Clin Genet"},{"key":"2025092503210991000_73.12.819.9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000163"},{"key":"2025092503210991000_73.12.819.10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate Hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2025092503210991000_73.12.819.11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAS.0000000000001000","article-title":"Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate Hydratase-deficient renal cell carcinoma","volume":"42","author":"Ohe","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2025092503210991000_73.12.819.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505917"},{"key":"2025092503210991000_73.12.819.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2010.01486.x"},{"key":"2025092503210991000_73.12.819.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.660502"},{"key":"2025092503210991000_73.12.819.15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cas.12601","article-title":"Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dub\u00e9 syndrome","volume":"106","author":"Furuya","year":"2015","journal-title":"Cancer Sci"},{"key":"2025092503210991000_73.12.819.16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajpath.2015.10.013","article-title":"Genome-Wide uniparental disomy and copy number variations in renal cell carcinomas associated with Birt-Hogg-Dub\u00e9 syndrome","volume":"186","author":"Iribe","year":"2016","journal-title":"Am J Pathol"},{"key":"2025092503210991000_73.12.819.17","doi-asserted-by":"crossref","DOI":"10.1111\/pin.12684","article-title":"Histopathological analysis of aggressive renal cell carcinoma harboring a unique germline mutation in fumarate hydratase","author":"Matsumoto","year":"2018","journal-title":"Pathol Int"},{"key":"2025092503210991000_73.12.819.18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/iju.13760","article-title":"Hereditary leiomyomatosis and renal cell cancer without cutaneous manifestations in two Japanese siblings","volume":"25","author":"Noguchi","year":"2018","journal-title":"Int J Urol"},{"key":"2025092503210991000_73.12.819.19","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1111\/1346-8138.14855","article-title":"Hereditary leiomyomatosis and renal cell cancer syndrome in which skin biopsy enabled diagnosis","volume":"46","author":"Matsuda","year":"2019","journal-title":"J Dermatol"},{"key":"2025092503210991000_73.12.819.20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/1346-8138.13019","article-title":"Novel splice site mutation in the fumarate hydratase (FH) gene is associated with multiple cutaneous leiomyomas in a Japanese patient","volume":"43","author":"Yoshinaga","year":"2016","journal-title":"J Dermatol"},{"key":"2025092503210991000_73.12.819.21","doi-asserted-by":"publisher","DOI":"10.1038\/ng849"},{"key":"2025092503210991000_73.12.819.22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/gcc.20663","article-title":"Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer","volume":"48","author":"Koski","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"2025092503210991000_73.12.819.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"2025092503210991000_73.12.819.24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.eururo.2015.07.008","article-title":"Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with Sarcomatoid and rhabdoid features","volume":"68","author":"Geynisman","year":"2015","journal-title":"Eur Urol"},{"key":"2025092503210991000_73.12.819.25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10637-017-0469-5","article-title":"Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: on-label but without evidence","volume":"35","author":"Adrianzen Herrera","year":"2017","journal-title":"Invest New Drugs"},{"key":"2025092503210991000_73.12.819.26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.anndiagpath.2017.04.007","article-title":"Programmed death-1 (PD-1) receptor\/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma","volume":"29","author":"Alaghehbandan","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"2025092503210991000_73.12.819.27","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0116"},{"key":"2025092503210991000_73.12.819.28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/PAS.0000000000000653","article-title":"Comprehensive immunohistochemical study of programmed cell death ligand 1 (PD-L1): analysis in 5536 cases revealed consistent expression in trophoblastic tumors","volume":"40","author":"Inaguma","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2025092503210991000_73.12.819.29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0715"},{"key":"2025092503210991000_73.12.819.30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccell.2019.01.002","article-title":"Antitumor responses in the absence of toxicity in solid tumors by targeting B7-H3 via chimeric antigen receptor T cells","volume":"35","author":"Du","year":"2019","journal-title":"Cancer Cell"},{"key":"2025092503210991000_73.12.819.31","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.90"},{"key":"2025092503210991000_73.12.819.32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith","year":"2017","journal-title":"Histopathology"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2020-206548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:21:18Z","timestamp":1758795678000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2020-206548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,11,19]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/jclinpath-2020-206548"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2020-206548","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]}}}